355 related articles for article (PubMed ID: 33254433)
1. Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms.
Fan W; Huang Y; Zheng H; Li S; Li Z; Yuan L; Cheng X; He C; Sun J
Biomed Pharmacother; 2020 Dec; 132():110915. PubMed ID: 33254433
[TBL] [Abstract][Full Text] [Related]
2. Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action.
Zhu GX; Zuo JL; Xu L; Li SQ
Pharmacol Res; 2021 Jul; 169():105647. PubMed ID: 33964471
[TBL] [Abstract][Full Text] [Related]
3. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach.
Zarneshan SN; Fakhri S; Khan H
Pharmacol Res; 2022 Mar; 177():106099. PubMed ID: 35092819
[TBL] [Abstract][Full Text] [Related]
4. The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice.
Zhu H; He YS; Ma J; Zhou J; Kong M; Wu CY; Mao Q; Lin G; Li SL
J Ethnopharmacol; 2021 Jan; 265():113271. PubMed ID: 32853742
[TBL] [Abstract][Full Text] [Related]
5. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
Xu R; Peng Y; Wang M; Fan L; Li X
J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression.
Hu C; Lau AJ; Wang R; Chang TKH
Eur J Pharmacol; 2017 Nov; 815():501-511. PubMed ID: 29031898
[TBL] [Abstract][Full Text] [Related]
7. Complex components of Shengmai formula interact with organic cation transporter 2 (OCT2) in MDCK cells.
Meng C; Zhong L; Lu T; Gu Q; Du X; Liu F; Xia C
J Ethnopharmacol; 2023 May; 308():116278. PubMed ID: 36813246
[TBL] [Abstract][Full Text] [Related]
8. Natural medicines for the treatment of fatigue: Bioactive components, pharmacology, and mechanisms.
Luo C; Xu X; Wei X; Feng W; Huang H; Liu H; Xu R; Lin J; Han L; Zhang D
Pharmacol Res; 2019 Oct; 148():104409. PubMed ID: 31446039
[TBL] [Abstract][Full Text] [Related]
9. Identification of NF-κB inhibitors following Shenfu injection and bioactivity-integrated UPLC/Q-TOF-MS and screening for related anti-inflammatory targets in vitro and in silico.
Li P; Lv B; Jiang X; Wang T; Ma X; Chang N; Wang X; Gao X
J Ethnopharmacol; 2016 Dec; 194():658-667. PubMed ID: 27771457
[TBL] [Abstract][Full Text] [Related]
10. Ginsenosides for cardiovascular diseases; update on pre-clinical and clinical evidence, pharmacological effects and the mechanisms of action.
Sarhene M; Ni JY; Duncan ES; Liu Z; Li S; Zhang J; Guo R; Gao S; Gao X; Fan G
Pharmacol Res; 2021 Apr; 166():105481. PubMed ID: 33549726
[TBL] [Abstract][Full Text] [Related]
11. One-month toxicokinetic study of SHENMAI injection in rats.
Yu J; Xin YF; Gu LQ; Gao HY; Xia LJ; You ZQ; Xie F; Ma ZF; Wang Z; Xuan YX
J Ethnopharmacol; 2014 Jun; 154(2):391-9. PubMed ID: 24747029
[TBL] [Abstract][Full Text] [Related]
12. Multi-layered effects of Panax notoginseng on immune system.
Yang C; Qu L; Wang R; Wang F; Yang Z; Xiao F
Pharmacol Res; 2024 Jun; 204():107203. PubMed ID: 38719196
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats.
Shi Y; Han B; Yu X; Qu S; Sui D
Pharm Biol; 2011 Sep; 49(9):900-6. PubMed ID: 21591990
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis.
Zhou P; Xie W; He S; Sun Y; Meng X; Sun G; Sun X
Cells; 2019 Feb; 8(3):. PubMed ID: 30823412
[No Abstract] [Full Text] [Related]
15. Ginsenoside Rg1 exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vitro.
Song Y; Zhao F; Zhang L; Du Y; Wang T; Fu F
Fitoterapia; 2013 Dec; 91():173-179. PubMed ID: 24035860
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the main active components in Shengmai formula mediated by organic anion transporter 1 (OAT1).
Hou J; Zhong L; Liu J; Liu F; Xia C
J Ethnopharmacol; 2022 Oct; 296():115515. PubMed ID: 35777609
[TBL] [Abstract][Full Text] [Related]
17. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy.
Liu H; Lu X; Hu Y; Fan X
Pharmacol Res; 2020 Nov; 161():105263. PubMed ID: 33127555
[TBL] [Abstract][Full Text] [Related]
18. The ginseng's fireness is associated with the lowering activity of liver Na(+)-K(+)-ATPase.
Xu X; Dou D
J Ethnopharmacol; 2016 Aug; 190():241-50. PubMed ID: 27288755
[TBL] [Abstract][Full Text] [Related]
19. Effects of ginsenosides from Panax ginseng on cell-to-cell communication function mediated by gap junctions.
Zhang YW; Dou DQ; Zhang L; Chen YJ; Yao XS
Planta Med; 2001 Jul; 67(5):417-22. PubMed ID: 11488454
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Determination and Analysis of Major Ginsenosides in Wild American Ginseng Grown in Tennessee.
Liang J; Chen L; Guo YH; Zhang M; Gao Y
Chem Biodivers; 2019 Jul; 16(7):e1900203. PubMed ID: 31197924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
